Document Detail


Dynorphin modulates dopamine D1-receptor mediated turning behavior in 6-hydroxydopamine-lesioned rats.
MedLine Citation:
PMID:  10925169     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We investigated if the potentiated turning response to a challenge with the partial dopamine D1 receptor agonist SKF-38393, as seen after priming with L-dihydroxyphenylalanine (DOPA) of unilaterally 6-hydroxydopamine-lesioned rats, can be modulated by infusion of dynorphin A (1-17) in the striatum. Seventeen days after the 6-hydroxydopamine lesion, rats received intrastriatal dynorphin (0. 08 or 3.85 microg) followed by L-DOPA (50 mg/kg i.p.) and were challenged 3 days later with SKF-38393 (3.0 mg/kg s.c.). Compared to controls, the lower dose of dynorphin caused an earlier onset of turning, while the higher dose decreased the response to SKF-38393. These findings suggest a dose-dependent modulatory role for striatal dynorphin in L-DOPA-priming of a D1-mediated behavioral response.
Authors:
S V van de Witte; H J Groenewegen; B Drukarch; P Voorn
Related Documents :
17498809 - A beam-walking apparatus to assess behavioural impairments in mptp-treated mice: pharma...
14769359 - Blockade of a2a receptors plus l-dopa after nigrostriatal lesion results in gad67 mrna ...
9671099 - 3-4-methylenedioxymethamphetamine-induced acute changes in dopamine transporter function.
20686519 - The features of reserpine-induced gastric mucosal lesions.
10688609 - D(2), but not d(1) dopamine receptor agonists potentiate cannabinoid-induced sedation i...
2046879 - Sulpiride has an antiaggressive effect in mice without markedly depressing motor activity.
3936529 - Effects of alfentanil on cerebral vascular reactivity in dogs.
6434749 - Sonographic depiction of endometrial changes occurring with ovulation induction.
17498809 - A beam-walking apparatus to assess behavioural impairments in mptp-treated mice: pharma...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Neuroscience letters     Volume:  290     ISSN:  0304-3940     ISO Abbreviation:  Neurosci. Lett.     Publication Date:  2000 Aug 
Date Detail:
Created Date:  2000-10-06     Completed Date:  2000-10-06     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7600130     Medline TA:  Neurosci Lett     Country:  IRELAND    
Other Details:
Languages:  eng     Pagination:  37-40     Citation Subset:  IM    
Affiliation:
Research Institute Neurosciences, Vrije Universiteit, Department of Anatomy, van der Boechorststraat 7, 1081 BT, The, Amsterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / pharmacology*
Adrenergic Agents / administration & dosage,  pharmacology
Animals
Behavior, Animal / drug effects*,  physiology*
Dopamine Agonists / pharmacology*
Dynorphins / administration & dosage,  metabolism,  physiology*
Immunohistochemistry
Injections, Intraventricular
Male
Oxidopamine / administration & dosage,  pharmacology*
Rats
Rats, Wistar
Receptors, Dopamine D1 / agonists,  physiology*
Chemical
Reg. No./Substance:
0/Adrenergic Agents; 0/Dopamine Agonists; 0/Receptors, Dopamine D1; 1199-18-4/Oxidopamine; 67287-49-4/2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 74913-18-1/Dynorphins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Repeated administration of high dose levodopa enhances hydroxyl radical production in the rat striat...
Next Document:  Accumulation of human alpha-synuclein in different cytoskeletons in Lewy bodies in brains of dementi...